home *** CD-ROM | disk | FTP | other *** search
- $Unique_ID{BRK03143}
- $Pretitle{}
- $Title{ergoloid mesylates}
- $Subject{Gerimal Rugby Hydergine Sandoz Vasodilator ergoloid mesylates
- senility dilating widening blood vessels flow brain}
- $Volume{}
- $Log{
- Hydergine*0314301.scf}
-
- Copyright (C) 1993 Publications International, Ltd.
-
-
- ergoloid mesylates
- ------------------------------------------------------------------------------
-
- BRAND NAMES (Manufacturers)
-
- ergoloid mesylates (various manufacturers)
- Gerimal (Rugby)
- Hydergine (Sandoz)
-
- TYPE OF DRUG
-
- Vasodilator
-
- INGREDIENT
-
- ergoloid mesylates
-
- DOSAGE FORMS
-
- Capsules, liquid (1 mg)
- Oral tablets (0.5 mg and 1 mg)
- Sublingual tablets (0.5 mg and 1 mg)
- Oral liquid (1 mg per ml, with 30% alcohol)
-
- STORAGE
-
- Ergoloid mesylates capsules, tablets, and oral liquid should be stored at
- room temperature in tightly closed, light-resistant containers. Never freeze
- this medication.
-
- USES
-
- This medication is used to reduce the symptoms associated with senility.
- It is not clear how ergoloid mesylates work, but it is thought that they act
- by dilating (widening) the blood vessels, thus increasing blood flow to the
- brain.
-
- TREATMENT
-
- In order to avoid stomach irritation, you can take the capsules, tablets,
- or oral liquid with food or milk. Be sure to measure the dose of the liquid
- form of this medication carefully with the dropper provided.
- The sublingual form of this medication must be placed under the tongue
- and allowed to dissolve completely. Try not to swallow for as long as
- possible, because the drug is more completely absorbed through the lining of
- the mouth than it is from the stomach. Do not drink any liquid, eat, or smoke
- for at least ten minutes after placing the tablet under the tongue.
- If you miss a dose of this medication, take the missed dose as soon as
- possible, unless it is almost time for the next dose. In that case, do not
- take the missed dose at all; just return to your regular dosing schedule. Do
- not double the next dose.
- It may take three or four weeks for the effects of this medication to
- become apparent.
-
- SIDE EFFECTS
-
- Minor.
-
- Blurred vision, dizziness, drowsiness, flushing, headache, irritation
- under the tongue (with the sublingual form only), light-headedness, loss of
- appetite, nasal congestion, nausea, stomach cramps, or vomiting. These side
- effects should disappear as your body adjusts to the medication.
- If you feel dizzy or light-headed, sit or lie down for a while; get up
- slowly from a sitting or reclining position, and be careful on stairs.
-
- Major.
-
- Tell your doctor about any side effects that are persistent or
- particularly bothersome. IT IS ESPECIALLY IMPORTANT TO TELL YOUR DOCTOR about
- a slowed heart rate.
-
- INTERACTIONS
-
- Ergoloid mesylates should not interact with other medications if they are
- used according to directions.
-
- WARNINGS
-
- * Tell your doctor about unusual or allergic reactions you have had to
- any medications, especially to ergoloid mesylates or ergot alkaloids (such as
- ergonovine, ergotamine, or bromocriptine).
- * Before starting to take this medication, be sure to tell your doctor if
- you now have or if you have ever had liver disease, low blood pressure,
- porphyria, severe mental illness, or a slowed heart rate.
- * Ergoloid mesylates may lessen your ability to adjust to the cold.
- Therefore, since you may experience increased sensitivity, do not expose your
- body to very cold temperatures for prolonged periods.
- * Your doctor may want you to take your pulse daily while you are using
- this medication. Contact your doctor if your pulse becomes slower than normal
- or if it drops below 50 beats per minute.
- * If this drug makes you dizzy or drowsy or blurs your vision, do not
- take part in any activity that requires alertness, such as driving a car or
- operating potentially dangerous equipment. Also, be careful going up and
- down stairs.
- * Some of these products contain the color additive FD&C Yellow No. 5
- (tartrazine), which can cause allergic-type reactions (rash, shortness of
- breath, fainting) in certain susceptible individuals.
-
- ----------------
-
- The material contained here is "FOR INFORMATION ONLY" and should not replace
- the counsel and advice of your personal physician. Promptly consulting your
- doctor is the best path to a quick and successful resolution of any medical
- problem.
-